Arturo Loaiza-Bonilla
Tracked across 1 events · 6 articles · First seen May 28, 2026 · Last active May 31, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Massive Bio announced the launch of its next-generation Reticulum Nexus product suite at ASCO 2026. This suite introduces a coordinated set of AI agents, intelligent calculators, signal engines, patient navigation tools, and physician referral workflows…
Impact: As Co-Founder and Chief Medical AI Officer of Massive Bio, Arturo Loaiza-Bonilla played a key role in the development and announcement of Reticulum Nexus, highlighting its innovative approach to oncology access.
May 28, 2026 · 6 articles
NEWSDESK
Track Arturo Loaiza-Bonilla live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard